3Yanoff M, Duker JS, Augsburger JJ, et al . Ophthalmology. St Louis: Mosby 2004.
4Hayreh SS. Prevalent misconceptions about acute retinal vascular occlusive disorders. Prog Ret Eye Res 2005 ;24(4) :493-419.
5Hayreh SS, Zimmennan MB. Central retinal artery occlusion: visual outcome. Am J Ophthalmol 2005 ; 140 ( 3 ) :376-391.
6Chia EM, Mitchell P, Rochtchina E, et al . Unilateral visual impairment and health related quality of life : the Blue Mountains Eye Study. Br J Ophthalmol 2003 ; 87 (4) : 392-395.
7Vu HTV, Keeffe JE, McCarty CA, et al. Impact of unilateral and bilateral vision loss on quality of life. Br J Ophthalmol 2005 ;89(3) :360-363.
8Feltgen N, Neubauer A, Jurklies B, et al. Multicenter study of the European assessment group for lysis in the eye (EAGLE) for the treatment of central retinal artery occlusion: design issues and implications. EAGLE study report no 1. Graefes Areb Clin Exp Ophthalmol 2006;244 (8) :950-956.
9Eric M, Aldrich, Andrew W, et al. Local intraarterial fibriuolysis administered in aliquots for the treatment of central retinal artery occlusion: the Johns Hopkins Hospital experience. Stroke 2008;39 (6): 1746-1750.
10Arnold M, Koerner U, Remonda L, et al. Comparison of intra-arterial thrombolysis with conventional treatment in patients with acute central retinal artery occlusion.J Neurol Neurosurg Psyehiatzy 2005 ;76 : 196-199.
